Core Scientific Announces First Quarter Fiscal Year 2026 Results

Recent Developments

  • Strengthened the capital structure through today's closing of a $3.3 billion offering of 7.75% senior secured notes due 2031, supporting strategic data center development projects.
  • Expanded the Company's total gross power capacity pipeline to 4.5 GW, including planned 1.5 GW expansions at each of the Company's Muskogee, Oklahoma and Pecos, Texas campuses.
  • Closed on the acquisition of land and power in Hunt County, Texas for approximately $233 million, which is expected to support ~430 MW of gross power capacity, with an approved ERCOT interconnection ramp schedule.
  • Billing for 243 MW of capacity, representing approximately $350 million in average annualized colocation GAAP revenue.

Core Scientific, Inc . ( NASDAQ: CORZ ), a leader in digital infrastructure for high-density colocation services ("HDC"), today announced financial results for the first quarter of 2026.

"Core Scientific is differentiated by our ability to combine capital readiness with speed to delivery," said Adam Sullivan, Chief Executive Officer of Core Scientific. "We are investing ahead of contracts, advancing ready-for-service dates and moving development forward across multiple sites. That execution capability is accelerating customer discussions and reinforcing the value of our high-density compute infrastructure platform."

First Quarter 2026 Financial Results

  • Total revenue was $115.2 million compared to $79.5 million in the first quarter of 2025.
    • Colocation revenue was $77.5 million, up from $8.6 million in the first quarter of 2025, driven by incremental billable customer power capacity delivered to our customer during the quarter.
    • Digital asset self-mining revenue was $30.1 million, down from $67.2 million in the first quarter of 2025, driven by the 45% decrease in bitcoin mined primarily due to the continued strategic shift to our colocation business and the 18% decrease in the average bitcoin price.
  • Gross profit was $30.1 million compared to $8.2 million in the same period last year.
  • Net loss was $347.2 million, compared to net income of $576.3 million in the first quarter of 2025. The net loss included $266.5 million of non-cash impairment charges, and a $30.8 million non-cash loss from changes in the fair value of warrants and contingent value rights.
  • Non-GAAP Adjusted EBITDA was $4.4 million, compared to $(6.1) million for the prior year period, driven by a $35.7 million increase in total revenue and a $4.1 million favorable change in fair value of digital assets, partially offset by a $17.5 million increase in cash cost of revenue and a $11.9 million increase in adjusted operating expenses.
  • Capital expenditures were $389.2 million, $129.9 million of which were funded by CoreWeave, Inc. pursuant to its existing colocation service agreements with the Company.
  • Liquidity was $1.04 billion as of March 31, 2026, consisting of $1.01 billion of cash and cash equivalents and $37.3 million of bitcoin.

Conference Call and Earnings Presentation

In conjunction with this release, Core Scientific, Inc. will host a conference call today, Wednesday, May 6, 2026, at 4:30 pm Eastern Time that will be webcast live. Adam Sullivan, Chief Executive Officer, Matt Brown, Chief Operating Officer, Jim Nygaard, Chief Financial Officer and Jon Charbonneau,Vice President, Investor Relations will host the call.

Investors with Internet access may listen to the live audio webcast via the Investor Relations page of the Core Scientific, Inc. website, http://investors.corescientific.com or by using the following link https://event.choruscall.com/mediaframe/webcast.html?webcastid=VZaoQ5yv .

A supplementary investor presentation for the first quarter 2026 may be accessed at https://investors.corescientific.com/news-events/presentations .

Audio Replay

An audio replay of the event will be archived on the Investor Relations section of the Company's website at http://investors.corescientific.com .

Upcoming Investor Events

Core Scientific will be attending the following investor events in May:

  • TD Cowen 54th Annual Technology, Media & Telecom Conference, May 28, 2026; and
  • B. Riley Annual Investor Conference, May 20, 2026

If applicable, live presentation webcasts and replay information will be available on the Company's Investor Relations website.

About Core Scientific

Core Scientific is a leader in designing, building and operating large scale, purpose-built data centers for high-density colocation ("HDC") services. Core Scientific operates facilities for high-density colocation services serving artificial intelligence-related ("AI") workloads and is a premier provider of digital infrastructure, software solutions and services to its third-party customers. The majority of the Company's revenue is derived from high-density colocation services, with the remainder derived from earning digital assets for the Company's own account and from digital asset mining hosting services. The Company is in the process of repurposing its remaining mining facilities to support its high-density colocation services business as circumstances allow. Core Scientific's facilities are located in Alabama (1), Georgia (2), Kentucky (1), North Carolina (1), North Dakota (1), Oklahoma (1) and Texas (4). To learn more, visit www.corescientific.com .

Special Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Forward-looking statements may include words such as "aim," "estimate," "plan," "project," "forecast," "goal," "intend," "will," "expect," "anticipate," "believe," "seek," "target" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company's ability to scale and grow its business, successfully complete construction of its data centers, source sufficient electrical energy, necessary long lead infrastructure components, supplies and equipment, the advantages and expected growth of the Company, the Company's ability to source and retain talent, and our ability to source and consummate acquisitions of entities holding suitable land and power. These statements are provided for illustrative purposes only and are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company's management. These forward-looking statements are not intended to serve, and must not be relied on by any investor, as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company.

These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially from those indicated or anticipated. These risks, assumptions and uncertainties include those described in Part I. Item 1A. — "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended December 31, 2025. If one or more of these risks or uncertainties materializes, or if underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.

There may be additional risks that the Company could not presently know or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date of this press release and should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this press release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. Accordingly, you should not place undue reliance on these forward-looking statements, which speak only as of the date they are made.

Core Scientific, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except par value)

March 31,
2026

December 31,
2025

Assets

Current Assets:

Cash and cash equivalents

$

1,005,148

$

311,378

Restricted cash, current portion

60,244

Digital assets

37,312

222,000

Customer funding receivable and other current assets

352,128

362,159

Total Current Assets

1,454,832

895,537

Property, plant and equipment, net

1,344,924

1,293,299

Operating lease right-of-use assets

105,986

108,484

Restricted cash, net of current portion

80,593

Other noncurrent assets

83,229

50,324

Total Assets

$

3,069,564

$

2,347,644

Liabilities and Stockholders' Deficit

Current Liabilities:

Accounts payable

$

218,857

$

126,106

Accrued expenses

364,479

511,957

Deferred revenue

219,555

127,561

Notes payable, current portion

993,944

Warrant liabilities, current portion

844,752

Other current liabilities

20,196

15,777

Total Current Liabilities

2,661,783

781,401

Convertible and other notes payable, net of current portion

1,061,651

1,060,325

Warrant liabilities, net of current portion

116,495

936,107

Deferred revenue, net of current portion

434,672

428,290

Other noncurrent liabilities

100,649

104,261

Total Liabilities

4,375,250

3,310,384

Commitments and contingencies

Stockholders' Deficit:

Preferred stock; $0.00001 par value; 2,000,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025

Common stock; $0.00001 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; 316,949 and 314,231 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively

3

3

Additional paid-in capital

3,188,202

3,183,960

Accumulated deficit

(4,493,891

)

(4,146,703

)

Total Stockholders' Deficit

(1,305,686

)

(962,740

)

Total Liabilities and Stockholders' Deficit

$

3,069,564

$

2,347,644

Certain prior year amounts have been reclassified for consistency with the current year presentation.

Core Scientific, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(Unaudited)

Three Months Ended March 31,

2026

2025

Revenue:

Colocation revenue

$

77,539

$

8,573

Digital asset self-mining revenue

30,105

67,179

Digital asset hosted mining revenue from customers

7,600

3,773

Total revenue

115,244

79,525

Cost of revenue:

Cost of Colocation services

33,618

8,106

Cost of digital asset self-mining

47,189

61,170

Cost of digital asset hosted mining services

4,331

2,036

Total cost of revenue

85,138

71,312

Gross profit

30,106

8,213

Decrease in fair value of digital assets

6,558

10,688

Loss on disposal of property, plant and equipment

13,638

6

Impairment of property, plant and equipment

266,488

Colocation organizational and site startup costs

8,665

11,667

Advisor fees

333

603

Selling, general and administrative

44,846

32,287

Operating loss

(310,422

)

(47,038

)

Non-operating expense (income), net:

Interest expense (income), net

4,857

(2,187

)

Change in fair value of warrants and contingent value rights

30,799

(621,464

)

Loss on legal settlements

500

Other non-operating expense, net

10

157

Total non-operating expense (income), net

36,166

(623,494

)

(Loss) income before income taxes

(346,588

)

576,456

Income tax expense

600

205

Net (loss) income

$

(347,188

)

$

576,251

Net (loss) income per share, basic

$

(1.06

)

$

1.42

Net (loss) income per share, diluted

$

(1.06

)

$

1.24

Weighted average shares outstanding, basic

322,911

315,186

Weighted average shares outstanding, diluted

322,911

363,314

Certain prior year amounts have been reclassified for consistency with the current year presentation.

Core Scientific, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands) (Unaudited)

Three Months Ended March 31,

2026

2025

Cash flows from Operating Activities:

Net (loss) income

$

(347,188

)

$

576,251

Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:

Depreciation and amortization

16,648

19,731

Loss on disposal of property, plant and equipment

13,638

6

Impairment of property, plant and equipment

266,488

Change in right-of-use assets

3,169

2,676

Stock-based compensation

17,761

16,185

Digital asset self-mining

(30,119

)

(67,441

)

Proceeds from sale of digital assets generated by self-mining revenues 1

208,249

Decrease in fair value of digital assets

6,558

10,688

Change in fair value of warrant liabilities

31,835

(634,280

)

Change in fair value of contingent value rights

(1,036

)

12,816

Amortization of debt discount

1,675

1,732

Changes in operating assets and liabilities:

Customer funding receivable and other current assets

10,107

(10,463

)

Accounts payable

5,874

(14,295

)

Accrued expenses

(16,361

)

2,712

Deferred revenue from colocation services

98,832

42,005

Deferred revenue from hosted mining services

(456

)

734

Other noncurrent assets and liabilities, net

(35,797

)

(4,098

)

Net cash provided by (used in) operating activities

249,877

(45,041

)

Cash flows from Investing Activities:

Purchases of property, plant and equipment

(389,226

)

(83,980

)

Proceeds from sales of property and equipment

2,629

Purchase of equity investments

(5,000

)

Investments in intangible assets

(55

)

(36

)

Net cash used in investing activities

(386,652

)

(89,016

)

Cash flows from Financing Activities:

Principal repayments of finance leases

(1,095

)

(509

)

Principal payments on debt

(3,955

)

Taxes paid related to net share settlement of equity awards

(21,722

)

Proceeds from exercise of warrants

81

266

Proceeds for the issuance of term loan facility, net

995,000

Issuance costs for term loan facility

(882

)

Net cash provided by (used in) financing activities

971,382

(4,198

)

Net increase (decrease) in cash, cash equivalents and restricted cash

834,607

(138,255

)

Cash, cash equivalents and restricted cash—beginning of period

311,378

836,980

Cash, cash equivalents and restricted cash—end of period

$

1,145,985

$

698,725

Certain prior year amounts have been reclassified for consistency with the current year presentation.

1 Proceeds from digital assets received as noncash revenue consideration liquidated upon management's discretion.

Core Scientific, Inc.

Segment Results

(in thousands, except percentages)

(Unaudited)

Three Months Ended March 31,

2026

2025

Colocation Segment

(in thousands, except percentages)

Colocation revenue:

License fees

$

59,195

$

5,995

Power fees passed through to customer

21,059

2,586

Maintenance and other

(2,715

)

(8

)

Total colocation revenue

77,539

8,573

Cost of colocation services:

Power fees passed through to customer

21,059

2,586

Depreciation expense

2,075

67

Employee compensation

2,986

1,295

Facility operations expense

6,755

3,852

Other segment items

743

306

Total cost of colocation services

33,618

8,106

Colocation gross profit

$

43,921

$

467

Colocation gross margin

57

%

5

%

Digital Asset Self-Mining Segment

Digital asset self-mining revenue

$

30,105

$

67,179

Cost of digital asset self-mining:

Power fees

27,271

30,319

Depreciation expense

13,909

19,259

Employee compensation

3,527

7,335

Facility operations expense

1,972

3,280

Other segment items

510

977

Total cost of digital asset self-mining

47,189

61,170

Digital Asset Self-Mining gross profit

$

(17,084

)

$

6,009

Digital Asset Self-Mining gross margin

(57

)%

9

%

Digital Asset Hosted Mining Segment

Digital asset hosted mining revenue from customers

$

7,600

$

3,773

Cost of digital asset hosted mining services:

Power fees

3,303

1,367

Depreciation expense

306

145

Employee compensation

427

332

Facility operations expense

234

148

Other segment items

61

44

Total cost of digital asset hosted mining services

4,331

2,036

Digital Asset Hosted Mining gross profit

$

3,269

$

1,737

Digital Asset Hosted Mining gross margin

43

%

46

%

Consolidated

Consolidated total revenue

$

115,244

$

79,525

Consolidated cost of revenue

$

85,138

$

71,312

Consolidated gross profit

$

30,106

$

8,213

Consolidated gross margin

26

%

10

%

Core Scientific, Inc.
N
on-GAAP Financial Measures
(Unaudited)

Adjusted EBITDA is a non-GAAP financial measure defined as our net (loss) income, adjusted to eliminate the effect of (i) interest income, interest expense, and other income (expense), net; (ii) provision for income taxes; (iii) depreciation and amortization; (iv) stock-based compensation expense; (v) loss on disposal and impairment of property, plant and equipment; (vi) site demolition costs incurred in connection with the conversion of existing facilities to colocation data center operations; (vii) change in fair value of warrant and contingent value rights; (viii) loss on legal settlements; (ix) post-emergence bankruptcy advisory costs incurred related to reorganization, and (x) certain additional non-cash items that do not reflect the performance of our ongoing business operations. For additional information, including the reconciliation of net income (loss) to Adjusted EBITDA, please refer to the table below. We believe Adjusted EBITDA is an important measure because it allows management, investors, and our Board of Directors to evaluate and compare our operating results, including our return on capital and operating efficiencies, from period-to-period by making the adjustments described above. In addition, it provides useful information to investors and others in understanding and evaluating our results of operations, as well as provides a useful measure for period-to-period comparisons of our business, as it removes the effect of net interest expense, taxes, certain non-cash items, variable charges and timing differences. Moreover, we have included Adjusted EBITDA in this earnings release because it is a key measurement used by our management internally to make operating decisions, including those related to operating expenses, evaluate performance, and perform strategic and financial planning.

The above items are excluded from our Adjusted EBITDA measure because these items are non-cash in nature or because the amount and timing of these items are not related to the current results of our core business operations which renders evaluation of our current performance, comparisons of performance between periods and comparisons of our current performance with our competitors less meaningful. However, you should be aware that when evaluating Adjusted EBITDA, we may incur future expenses similar to those excluded when calculating this measure. Our presentation of this measure should not be construed as an inference that its future results will be unaffected by unusual items. Further, this non-GAAP financial measure should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). We compensate for these limitations by relying primarily on GAAP results and using Adjusted EBITDA on a supplemental basis. Our computation of Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies because not all companies calculate this measure in the same fashion. You should review the reconciliation of net (loss) income to Adjusted EBITDA below and not rely on any single financial measure to evaluate our business.

The following table reconciles the non-GAAP financial measure to the most directly comparable U.S. GAAP financial performance measure, which is net (loss) income, for the periods presented (in thousands):

Three Months Ended March 31,

2026

2025

Adjusted EBITDA

Net (loss) income

$

(347,188

)

$

576,251

Adjustments:

Interest expense (income), net

4,857

(2,187

)

Income tax expense

600

205

Depreciation and amortization

16,553

19,731

Stock-based compensation expense

17,761

16,185

Loss on disposal of property, plant and equipment

13,638

6

Impairment of property, plant and equipment

266,488

Site conversion demolition costs

4,442

Change in fair value of warrants and contingent value rights

30,799

(621,464

)

Loss on legal settlements

500

Post-emergence bankruptcy advisory costs

317

603

Other

27

157

Adjusted EBITDA

$

4,352

$

(6,071

)

Please follow us on:

https://www.linkedin.com/company/corescientific/

https://twitter.com/core_scientific

https://www.youtube.com/@Core_Scientific

Investors:
ir@corescientific.com

Media:
press@corescientific.com

News Provided by Business Wire via QuoteMedia

CORZ
The Conversation (0)

Interactive Chart

Latest Press Releases

Related News